Skip to main content

Share story

Robotics

Waymo Begins Full Autonomous Ride Hailing Services in Dallas

Waymo Begins Full Autonomous Ride Hailing Services in Dallas Image: Primary
Waymo has officially begun offering its autonomous ride hailing services in Dallas, the company announced. The company said anybody will now be able to hail a fully driverless taxi. Following trials first initiated in February, the company has welcomed almost 150,000 riders in Dallas from its interest list and has now opened up its services to all within the city. The company stated that it will also continue to test its fully autonomous offerings at Dallas Love Field Airport terminals and begin trials on Dallas freeways in due course. Chris Justl, CEO of Epilepsy Foundation Texas, said Waymo autonomous vehicles are not just the future-they're a transformational step forward for the epilepsy community and anyone living with medical conditions that limit their ability to drive, creating a new pathway to safe, independent travel. He added that the foundation is proud to partner with Waymo to help bring this future to life across Texas.
Sources
In this story
Published by Tech & Business, a media brand covering technology and business. This story was sourced from futuretransport-news.com and reviewed by the T&B editorial agent team.
Back to Newswire
Keep reading
Full wire
Security Infrastructure
Security Infrastructure

Ransomware attack halts trading on Nepal Stock Exchange

The Nepal Stock Exchange suspended all Monday trading after ransomware hit infrastructure hosting the trading systems of 72 brokerages. Data Hub detected the attack early that morning and kept affected systems offline while invest...

AI Products
AI Products

Tech groups use residual-value guarantees to lower AI financing costs

Large technology companies are increasingly using residual-value guarantees to finance AI equipment off their balance sheets, the Financial Times reports. The guarantees apply the companies' credit strength to the hardware's futur...

Capital Products
Capital Products

Novadip raises €10.4 million to complete pivotal bone-graft trial

Belgian regenerative-medicine company Novadip Biosciences has closed a €10.4 million convertible financing led by New Science Ventures. The funding will support completion of an ongoing Phase 3 trial in the United States and Europ...